Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

Rhea-AI Summary

Acutus Medical (Nasdaq: AFIB) will announce its Q4 and full year 2022 financial results on March 16, 2023. The release will be followed by a conference call at 1:30 PM PT / 4:30 PM ET to discuss key financial results and recent developments. Interested participants can access the call via a registration link. A webinar will also be accessible through the investor relations website, with a replay made available post-call.

Positive

• Upcoming release of Q4 and full year 2022 financial results may provide insights into company performance.
• Networking opportunity through the conference call may enhance investor engagement.

Negative

• None.

CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full year 2022 financial results on Thursday, March 16, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website.

About Acutus Medical
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact
Caroline Corner
ICR Westwicke
D: 415-202-5678
caroline.corner@westwicke.com 

Media Contact
Peter Neems
(442) 232-6094
peter.neems@acutus.com

FAQ

When will Acutus Medical release its Q4 2022 financial results?

Acutus Medical will release its Q4 2022 financial results on March 16, 2023.

What time is the Acutus Medical conference call scheduled?

The conference call is scheduled for 1:30 PM PT / 4:30 PM ET on March 16, 2023.

How can I access the Acutus Medical conference call?

You can access the call by registering through the provided link in the press release.

Will there be a replay of the Acutus Medical call available?

Yes, a replay of the conference call will be available on the company’s investor relations website after the event.